This indicates that CLCF1 is likely a “lipocytokine” in serum or cerebrospinal fluid and, that lipoprotein may regulate the neurotrophic and metabolic functions of this cytokine as well as its pathological role in FSGS. This evidence concerns the gene CLCF1 and focal segmental glomerulosclerosis.